Delivery Order SPE2DB22D2206-SPE2DB25FJH00
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for supply of Emverm 100 mg tablet chewable unit dose formulations. This competitively awarded, non-set-aside contract carries a ceiling value of $4,208.18 under a firm fixed price arrangement, with an ultimate completion date of June 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $11,190.41 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded delivery order represents a single-item pharmaceutical procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,232.22 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of supply on August 19, 2025. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Emverm 100 mg tablet chewables in unit dose packaging, with a ceiling value of $1,559.56. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by May 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract...
- The Defense Logistics Agency awarded a $22,395.03 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Emverm 100 mg tablet chewables under a firm fixed-price contract. The contract, which is classified as a child award under a larger indefinite delivery vehicle, requires performance completion by June 20, 2025, with fulfillment at the vendor's Conshohocken, Pennsylvania location. This delivery order was competitively awarded without any set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $6,317.21 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units under delivery order contract 4569293882. The award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed price, competitively awarded contract with no set-aside designation. Performance will be conducted at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,214.32 to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Emverm 100 mg tablet chewable units of use. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by June 12, 2025. The award is being performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Emverm 100 mg tablet chewable units of use, with a ceiling value of $3,152.63. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by April 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $125,392.88 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of issue on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $19,065.20 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units. This non-competitive, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJH00Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Emverm 100 mg tablet chewable units of use, with a ceiling value of $7,266.59. This competitively awarded, firm fixed-price delivery order is set to conclude by August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition based on AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to deliver brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 8/7/25 |